Related Experiment Video
Updated: Feb 16, 2026

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
Published on: December 12, 2025
Autophagy: A new treatment strategy for MSC-based therapy in acute kidney injury (Review)
Haoyuan Jia1, Yongmin Yan1, Zhaofeng Liang1
1Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China.
Abstract:
Acute kidney injury (AKI) is a common and serious medical condition associated with poor health outcomes. Autophagy is a conserved multistep pathway that serves a major role in many biological processes and diseases. Recent studies have demonstrated that autophagy is induced in proximal tubular cells during AKI. Autophagy serves a pro‑survival or pro‑death role under certain conditions. Furthermore, mesenchymal stem cells (MSCs) have therapeutic potential in the repair of renal injury. This review summarizes the recent progress on the role of autophagy in AKI and MSCs‑based therapy for AKI. Further research is expected to prevent and treat acute kidney injury.
Insights
Acute kidney injury (AKI) involves autophagy in kidney cells. Mesenchymal stem cell therapy shows promise for treating AKI, offering potential for improved patient outcomes.
Area of Science:
- Nephrology
- Cell Biology
- Regenerative Medicine
Background:
- Acute kidney injury (AKI) is a prevalent clinical condition linked to adverse health outcomes.
- Autophagy, a fundamental cellular process, plays a critical role in various biological functions and diseases.
- Recent evidence indicates autophagy is activated in proximal tubular cells during AKI.
Purpose of the Study:
- To review the current understanding of autophagy's role in AKI.
- To explore the therapeutic potential of mesenchymal stem cells (MSCs) for AKI treatment.
- To highlight recent advancements in AKI research.
Main Methods:
- Literature review of recent studies on autophagy and AKI.
- Analysis of research on MSC-based therapies for renal injury.
- Synthesis of findings regarding autophagy's dual role (pro-survival/pro-death) in AKI.
Main Results:
- Autophagy is demonstrably induced in proximal tubular cells during AKI.
- Mesenchymal stem cells exhibit therapeutic potential in repairing renal damage.
- Autophagy's specific role in AKI can be context-dependent, acting as either a survival or death mechanism.
Conclusions:
- Autophagy is a key player in the pathophysiology of AKI.
- MSC-based therapies represent a promising avenue for AKI treatment.
- Further investigation is crucial for developing effective AKI prevention and treatment strategies.
Related Concept Videos
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Mesenchymal Stem Cells
Acute Kidney Injury VI: Nursing Management

